Elevated bone alkaline phosphatase not mediated by metastasis in a patient with renal cancer
DOI:
https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v37i2.621Keywords:
alkaline phosphatase, bone alkaline phosphatase, renal cell carcinomaAbstract
A 63-year old man was seen in the outpatient clinic because of renal cancer and elevation in bone alkaline phosphatase measured by monoclonal
antibodies assay. Known causes of bone isoenzyme augmentation, including bone metastases, were ruled out. The tumoral origin of the isoenzyme
was diagnosed because after removal of the tumor the enzymatic levels fell sharply. Several alkaline phosphatase isoenzymes can be produced
and secreted by tumors as a paraneoplasic manifestation and their elevation could be a manifestation of an occult neoplasia. Furthermore the
monitoring of their blood levels can be useful means of treatment response and a tool to monitoring recurrence if a sharp decrease after removal
of the tumor is observed
Downloads
References
Panadero García AMT. Formas múltiples de fosfatasa alcalina. Revista Química Clínica (Barcelona, España). 1986; 5(3):257-63.
Friedman LS. Enzymatic measures of cholestasis (eg, alkaline phosphatase, 5’-nucleotidase, gamma-glutamyl transpeptidase). Up To Date (acceso en noviembre de 2016).
Chisholm GD. Nephrogenic ridge tumors and their syndromes. Ann N Y Acad Sci. 1974; 230:403-23. DOI: https://doi.org/10.1111/j.1749-6632.1974.tb14474.x
Chuang YC, Lin AT, Chen KK, et al. Paraneoplastic elevation of serum alkaline phosphatase in renal cell carcinoma: incidence and implication on prognosis. J Urol.1997; 158(5):1684-7. DOI: https://doi.org/10.1016/S0022-5347(01)64095-3
Fishman WH, Inglis NI, Stolbach LL, et al. A serum alkaline phosphatase isoenzyme of human neoplastic cell origin. Cancer Res. 1968; 28(1):150-4.
Stolbach LL, Krant MJ, Fishman WH. Ectopic Production of an Alkaline Phosphatase Isoenzyme in Patients with Cancer. N Engl J Med. 1969; 281(14):757-62. DOI: https://doi.org/10.1056/NEJM196910022811403
Nathanson L, Fishman WH. New observations on the Regan isoenzyme of alkaline phosphatase in cáncer patients. Cancer 1971; 27:1388-97. DOI: https://doi.org/10.1002/1097-0142(197106)27:6<1388::AID-CNCR2820270619>3.0.CO;2-0
Bukowczan J, Pattman S, Jenkinson F, et al. Regan isoenzyme of alkaline phosphatase as a tumour marker for renal cell carcinoma. Ann Clin Biochem. 2014; 51(5): 611-4. DOI: https://doi.org/10.1177/0004563214526169
Hada T, Higashino K, Okochi T, et al. Kasahara-variant alkaline phosphatase in a renal cell carcinoma. Clin Chim Acta. 1978; 89(2):311-6. DOI: https://doi.org/10.1016/0009-8981(78)90330-3
Whitaker KB, Eckland D, Hodgson HJF, et al. A variant alkaline phosphatase in renal cell carcinoma. Clin Chem. 1982; 28:374-7. DOI: https://doi.org/10.1093/clinchem/28.2.374
Timperley WR. Alkaline-phosphatase-secreting tumour of lung. Lancet 1968; 2(7563):356. DOI: https://doi.org/10.1016/S0140-6736(68)90572-2
Warnes T W, Timperley W R, Hine P, et al. Pancreatic alkaline phosphatase and a tumour variant. Gut. 1972; 13(7):513-9. DOI: https://doi.org/10.1136/gut.13.7.513
Narayanan S. Alkaline phosphatase as tumor marker. Ann Clin Lab Sci. 1983; 13(2):133-6.
Downloads
Published
Issue
Section
License
Copyright (c) 2017 Revista del Hospital Italiano de Buenos Aires
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
